You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Afuresertib

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteer Trial in Suzhou ([14C]Afuresertib)

Not yet recruiting
  • Healthy Volunteer
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 3, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Korea, Republic of, United States (Phase I and Phase II:

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Phase I and Phase II: LAE001/prednisone + afuresertib
  • Tucson, Arizona
  • +16 more
Nov 30, 2022

Solid Tumor, NSCLC, Cervical Cancer Trial in China (Afuresertib, Nab paclitaxel, Docetaxel)

Recruiting
  • Solid Tumor
  • +5 more
  • Afuresertib
  • +3 more
  • Beijing, Beijing, China
  • +4 more
Jul 15, 2022

Breast Cancer Trial in China, United States (Afuresertib)

Recruiting
  • Breast Cancer
  • Afuresertib
  • Santa Monica, California
  • +11 more
Nov 30, 2022

Solid Tumor, TNBC - Triple-Negative Breast Cancer Trial in Bengbu, Beijing (LAE005 + Afuresertib + Nab-Paclitaxel, LAE005 +

Recruiting
  • Solid Tumor
  • TNBC - Triple-Negative Breast Cancer
  • LAE005 + Afuresertib + Nab-Paclitaxel
  • +3 more
  • Bengbu, Anhui, China
  • +1 more
May 19, 2022

Tumors, Haematologic Trial in Japan (Afuresertib)

Terminated
  • Neoplasms, Haematologic
  • Afuresertib
  • Aichi, Japan
  • +4 more
Aug 3, 2021

Cancer Trial in Worldwide (GSK2110183 (afuresertib))

Completed
Has Results
  • Cancer
  • GSK2110183 (afuresertib)
  • Baltimore, Maryland
  • +7 more
Jun 20, 2019

Cancer Trial in Melbourne (Afuresertib GC - Fasted State, Afuresertib HPMC capsule - Fasted State, Afuresertib ECT - Fasted

Completed
  • Cancer
  • Afuresertib GC - Fasted State
  • +5 more
  • Melbourne, Victoria, Australia
    GSK Investigational Site
Nov 8, 2017

Cancer Trial in Randwick (GSK2110183 Gelatin Capsule, GSK2110183 IR Tablet)

Completed
  • Cancer
  • GSK2110183 Gelatin Capsule
  • GSK2110183 IR Tablet
  • Randwick, New South Wales, Australia
    GSK Investigational Site
Nov 8, 2017

Chronic Lymphocytic Leukemia (CLL) Trial in Toronto (Ofatumumab with GSK2110183)

Completed
Has Results
  • Chronic Lymphocytic Leukemia (CLL)
  • Ofatumumab with GSK2110183
  • Toronto, Ontario, Canada
    University Health Network-Princess Margaret Hospital
Sep 20, 2019

Cancer Trial in Seoul, Taipei (Afuresertib, Paclitaxel)

Completed
  • Cancer
  • Seoul, Korea, Republic of
  • +4 more
Apr 7, 2017

Cancer Trial (Afuresertib, Enzalutamide, Abiraterone)

Withdrawn
  • Cancer
  • Afuresertib
  • +3 more
  • (no location specified)
Oct 5, 2016

Cancer Trial in Cary (Afuresertib, Carfilzomib)

Terminated
  • Cancer
  • Cary, North Carolina
    Novartis Investigative Site
May 3, 2016